open access

Vol 85, No 2 (2014)
ARTICLES
Get Citation

The effect of prolactin and apolipoprotein E gene polymorphism on cognitive functions of menopausal women

Iwona Bojar, Dorota Raczkiewicz, Artur Wdowiak, Alfred Owoc
DOI: 10.17772/gp/1703
·
Ginekol Pol 2014;85(2).

open access

Vol 85, No 2 (2014)
ARTICLES

Abstract

Objective: The objective of the study was to analyze a possible association between cognitive functions and level of prolactin in menopausal women with different polymorphisms of apolipoprotein E gene (APOE). The examined population included women from the south-eastern part of Poland; aged 50-65 years; at least 2 years after their last menstruation; in good health; with at least primary education, FSH>30 mlU/ml. The MoCA test (Montreal Cognitive Assessment Test) allowed us to exclude women with signs of dementia. The cognitive functions assessment was conducted with the CNS-VitalSigns diagnostic equipment (Polish version). The prolactin designations were conducted by SYNEVO – an accredited laboratory. The examination of APOE polymorphism was performed using the multiplex-PCR method. The results were statistically analyzed. Results and conclusion: Higher level of prolactin turned out to be associated with better test results in the following areas: NCI, memory, verbal memory, psychomotor speed and concentration. Women with higher level of prolactin had better results in NCI, psychomotor speed and verbal memory tests. The test results of other cognitive function were not unequivocally related to higher levels of prolactin. Thus, it was not possible to conclude that the presence of APOE polymorphism is related to the effect of prolactin on cognitive functions of the examined menopausal women.

Abstract

Objective: The objective of the study was to analyze a possible association between cognitive functions and level of prolactin in menopausal women with different polymorphisms of apolipoprotein E gene (APOE). The examined population included women from the south-eastern part of Poland; aged 50-65 years; at least 2 years after their last menstruation; in good health; with at least primary education, FSH>30 mlU/ml. The MoCA test (Montreal Cognitive Assessment Test) allowed us to exclude women with signs of dementia. The cognitive functions assessment was conducted with the CNS-VitalSigns diagnostic equipment (Polish version). The prolactin designations were conducted by SYNEVO – an accredited laboratory. The examination of APOE polymorphism was performed using the multiplex-PCR method. The results were statistically analyzed. Results and conclusion: Higher level of prolactin turned out to be associated with better test results in the following areas: NCI, memory, verbal memory, psychomotor speed and concentration. Women with higher level of prolactin had better results in NCI, psychomotor speed and verbal memory tests. The test results of other cognitive function were not unequivocally related to higher levels of prolactin. Thus, it was not possible to conclude that the presence of APOE polymorphism is related to the effect of prolactin on cognitive functions of the examined menopausal women.
Get Citation

Keywords

menopause, prolactin, cognitive functions

About this article
Title

The effect of prolactin and apolipoprotein E gene polymorphism on cognitive functions of menopausal women

Journal

Ginekologia Polska

Issue

Vol 85, No 2 (2014)

DOI

10.17772/gp/1703

Bibliographic record

Ginekol Pol 2014;85(2).

Keywords

menopause
prolactin
cognitive functions

Authors

Iwona Bojar
Dorota Raczkiewicz
Artur Wdowiak
Alfred Owoc

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl